What does Lucid Diagnostics Inc. do?
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship…
What is Lucid Diagnostics Inc.'s P/E and P/B ratio?
Lucid Diagnostics Inc. has a P/E ratio of -0.7 and a P/B ratio of 5.73.
What is Lucid Diagnostics Inc.'s debt-to-equity ratio?
Lucid Diagnostics Inc. has a debt-to-equity ratio of 2.28.
How much does Lucid Diagnostics Inc. owe compared with what it owns?
Lucid Diagnostics Inc. owes $0.72 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Lucid Diagnostics Inc.'s Positivity rank?
Lucid Diagnostics Inc. is ranked #5,510 of 6,774 companies globally and #3,006 of 4,000 in United States on PositoAI, with a Positivity Score of 17,111.
Does Lucid Diagnostics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Lucid Diagnostics Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 16 Oct 2026). It has no yellow flags.
Where can I read the latest news about Lucid Diagnostics Inc.?
Recent headlines about Lucid Diagnostics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Lucid Diagnostics Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Lucid Diagnostics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.